You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
先瑞達醫療(06669.HK)升逾12% 獲BSC溢價31.6%要約收購最多65%股份
阿思達克 12-12 09:31
先瑞達醫療(06669.HK)公布,要約人Boston Scientific Group plc提出自願有條件部分現金要約,以向合資格股東收購公司最多2.037億股股份,佔已發行股本的65%,每股現金作價20元,較前收市價15.2元溢價31.6%,部分要約估值為40.74億元。要約人擬於部分要約完成後維持公司的上市地位。 要約人已從IU股東,即CMI、CIW、Cosmic Elite及Bliss Way Limited接獲不可撤回承諾,以就相關股份接納部分要約。要約人由Boston Scientific Corporation(BSC)全資擁有。BSC是一家開發、製造和商業化用於心臟科、外周介入、內窺鏡、泌尿科和神經調節等專業領域的微創介入醫療器械的跨國醫療器械公司,股份在紐約證券交易所上市。要約人預期本次部分要約將整合雙方的核心競爭力,並有望創造重大的戰略價值。於部分要約完成後,股東將鎖定彼等所提呈股份的重大價值。 先瑞達醫療今日高開15%,最高見18.48元。現報17.14元,升12.76%,成交244.7萬股,涉資4,300.13萬元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account